Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 4202437, 11 pages
http://dx.doi.org/10.1155/2016/4202437
Research Article

SOD2 Mediates Amifostine-Induced Protection against Glutamate in PC12 Cells

1Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China
2Department of Anesthesiology, Xi’an No. 4 Hospital, Xi’an 710032, China
3Department of General Surgery, Fuzhou General Hospital of Nanjing Military Command, Fuzhou 350025, China
4Department of Anesthesiology, Wuhan General Hospital of Guangzhou Military Command, Wuhan 430070, China
5Department of Gastrointestinal Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an 710032, China

Received 15 July 2015; Revised 31 August 2015; Accepted 1 September 2015

Academic Editor: Ryuichi Morishita

Copyright © 2016 Ji Jia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Won, J. Kim, G. F. Cittolin-Santos, and R. A. Swanson, “Assessment at the single-cell level identifies neuronal glutathione depletion as both a cause and effect of ischemia-reperfusion oxidative stress,” Journal of Neuroscience, vol. 35, no. 18, pp. 7143–7152, 2015. View at Publisher · View at Google Scholar
  2. X. Y. Lu, H. D. Wang, J. G. Xu, K. Ding, and T. Li, “Deletion of Nrf2 exacerbates oxidative stress after traumatic brain injury in mice,” Cellular and Molecular Neurobiology, vol. 35, no. 5, pp. 713–721, 2015. View at Publisher · View at Google Scholar
  3. M. Romanucci and L. Della Salda, “Oxidative stress and protein quality control systems in the aged canine brain as a model for human neurodegenerative disorders,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 940131, 8 pages, 2015. View at Publisher · View at Google Scholar
  4. K. A. Radermacher, K. Wingler, F. Langhauser et al., “Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress,” Antioxidants & Redox Signaling, vol. 18, no. 12, pp. 1418–1427, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S.-H. Kim, S.-H. Kim, J.-H. Lee et al., “Superoxide dismutase gene (SOD1, SOD2, and SOD3) polymorphisms and antituberculosis drug-induced hepatitis,” Allergy, Asthma and Immunology Research, vol. 7, no. 1, pp. 88–91, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-H. Wang, S.-B. Wu, Y.-T. Wu, and Y.-H. Wei, “Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging,” Experimental Biology and Medicine, vol. 238, no. 5, pp. 450–460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Fukui and B. T. Zhu, “Mitochondrial superoxide dismutase SOD2, but not cytosolic SOD1, plays a critical role in protection against glutamate-induced oxidative stress and cell death in HT22 neuronal cells,” Free Radical Biology and Medicine, vol. 48, no. 6, pp. 821–830, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Xu, J. F. Emery, Y.-B. Ouyang, L. A. Voloboueva, and R. G. Giffard, “Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia,” Glia, vol. 58, no. 9, pp. 1042–1049, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. I. N. Zelko, T. J. Mariani, and R. J. Folz, “Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression,” Free Radical Biology and Medicine, vol. 33, no. 3, pp. 337–349, 2002. View at Publisher · View at Google Scholar
  10. A. Donneys, C. N. Tchanque-Fossuo, J. T. Blough, N. S. Nelson, S. S. Deshpande, and S. R. Buchman, “Amifostine preserves osteocyte number and osteoid formation in fracture healing following radiotherapy,” Journal of Oral and Maxillofacial Surgery, vol. 72, no. 3, pp. 559–566, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Mukherjee, B. L. Carroll, J. L. Spees, and E. R. Delay, “Pre-treatment with amifostine protects against cyclophosphamide-induced disruption of taste in mice,” PLoS ONE, vol. 8, no. 4, Article ID e61607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Grdina, J. S. Murley, Y. Kataoka et al., “Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 3, pp. 886–896, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. S. Murley, Y. Kataoka, K. L. Baker, A. M. Diamond, W. F. Morgan, and D. J. Grdina, “Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha,” Radiation Research, vol. 167, no. 4, pp. 465–474, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Yunes, C. R. Estrella, S. García, H. E. Lara, and R. Cabrera, “Postnatal administration of allopregnanolone modifies glutamate release but not BDNF content in striatum samples of rats prenatally exposed to ethanol,” BioMed Research International, vol. 2015, Article ID 734367, 6 pages, 2015. View at Publisher · View at Google Scholar
  15. C. Girbovan and H. Plamondon, “Resveratrol downregulates type-1 glutamate transporter expression and microglia activation in the hippocampus following cerebral ischemia reperfusion in rats,” Brain Research, vol. 1608, pp. 203–214, 2015. View at Publisher · View at Google Scholar
  16. R. M. Guerriero, C. C. Giza, and A. Rotenberg, “Glutamate and GABA imbalance following traumatic brain injury,” Current Neurology and Neuroscience Reports, vol. 15, no. 5, article 27, 2015. View at Publisher · View at Google Scholar
  17. R. J. Buchanan, K. Gjini, D. Darrow, G. Varga, J. L. Robinson, and Z. Nadasdy, “Glutamate and GABA concentration changes in the globus pallidus internus of Parkinson's patients during performance of implicit and declarative memory tasks: a report of two subjects,” Neuroscience Letters, vol. 589, pp. 73–78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Son, S. J. Byun, and H.-O. Pae, “Involvement of heme oxygenase-1 expression in neuroprotection by piceatannol, a natural analog and a metabolite of resveratrol, against glutamate-mediated oxidative injury in HT22 neuronal cells,” Amino Acids, vol. 45, no. 2, pp. 393–401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Stanciu, Y. Wang, R. Kentor et al., “Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures,” The Journal of Biological Chemistry, vol. 275, no. 16, pp. 12200–12206, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Wang, A. Shanmugam, S. Markand, E. Zorrilla, V. Ganapathy, and S. B. Smith, “Sigma 1 receptor regulates the oxidative stress response in primary retinal Müller glial cells via NRF2 signaling and system xc-, the Na+-independent glutamate-cystine exchanger,” Free Radical Biology and Medicine, vol. 86, pp. 25–36, 2015. View at Publisher · View at Google Scholar
  21. W. Huang, W. B. Xie, D. Qiao et al., “Caspase-11 plays an essential role in methamphetamine-induced dopaminergic neuron apoptosis,” Toxicological Sciences, vol. 145, no. 1, pp. 68–79, 2015. View at Publisher · View at Google Scholar
  22. D. Wang, T. Q. Guo, Z. Y. Wang et al., “ERKs and mitochondria-related pathways are essential for glycyrrhizic acid-mediated neuroprotection against glutamate-induced toxicity in differentiated PC12 cells,” Brazilian Journal of Medical and Biological Research, vol. 47, no. 9, pp. 773–779, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Tian, S. Sui, J. Huang, J.-P. Bai, T.-S. Ren, and Q.-C. Zhao, “Neuroprotective effects of Arctium lappa L. roots against glutamate-induced oxidative stress by inhibiting phosphorylation of p38, JNK and ERK 1/2 MAPKs in PC12 cells,” Environmental Toxicology and Pharmacology, vol. 38, no. 1, pp. 189–198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Heyland, J. Muscedere, P. E. Wischmeyer et al., “A randomized trial of glutamine and antioxidants in critically Ill patients,” The New England Journal of Medicine, vol. 368, no. 16, pp. 1489–1497, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Roberts, L. Myatt, C. Y. Spong et al., “Vitamins C and E to prevent complications of pregnancy-associated hypertension,” The New England Journal of Medicine, vol. 362, no. 14, pp. 1282–1291, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. C. Petersen, R. G. Thomas, M. Grundman et al., “Vitamin E and donepezil for the treatment of mild cognitive impairment,” The New England Journal of Medicine, vol. 352, no. 23, pp. 2379–2388, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. P. A. Felice, N. S. Nelson, E. E. Page et al., “Amifostine reduces radiation-induced complications in a murine model of expander-based breast reconstruction,” Plastic and Reconstructive Surgery, vol. 134, no. 4, pp. 551–560, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. A. A. Merter, B. Mayir, O. Erdogan, and T. Colak, “Protective effects of amifostine on ischemia-reperfusion injury of rat kidneys,” Indian Journal of Pharmacology, vol. 47, no. 2, pp. 185–189, 2015. View at Publisher · View at Google Scholar
  29. M. Yang, M.-S. Song, S.-H. Kim et al., “Cytotoxicity of gamma-ray in rat immature hippocampal neurons,” Journal of Veterinary Science, vol. 12, no. 3, pp. 203–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. M. Celotto, Z. Liu, A. P. Vandemark, and M. J. Palladino, “A novel Drosophila SOD2 mutant demonstrates a role for mitochondrial ROS in neurodevelopment and disease,” Brain and Behavior, vol. 2, no. 4, pp. 424–434, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Raimundo, “Mitochondrial pathology: stress signals from the energy factory,” Trends in Molecular Medicine, vol. 20, no. 5, pp. 282–292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Wang, Y. Liu, X. Liu et al., “Resveratrol protects neurons and the myocardium by reducing oxidative stress and ameliorating mitochondria damage in a cerebral ischemia rat model,” Cellular Physiology and Biochemistry, vol. 34, no. 3, pp. 854–864, 2014. View at Publisher · View at Google Scholar
  33. C. Nieder, N. H. Andratschke, N. Wiedenmann, and M. Molls, “Prevention of radiation-induced central nervous system toxicity: a role for amifostine?” Anticancer Research, vol. 24, no. 6, pp. 3803–3809, 2004. View at Google Scholar · View at Scopus
  34. D. Carone, L. Librizzi, A. Cattalini et al., “Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia,” Brain Research, vol. 1615, pp. 31–41, 2015. View at Publisher · View at Google Scholar
  35. C. Winter, C. Bell, T. Whyte, J. Cardinal, D. Macfarlane, and S. Rose, “Blood–brain barrier dysfunction following traumatic brain injury: correlation of Ktrans (DCE-MRI) and SUVR (99mTc-DTPA SPECT) but not serum S100B,” Neurological Research, vol. 37, no. 7, pp. 599–606, 2015. View at Publisher · View at Google Scholar
  36. M. T. Gray and J. M. Woulfe, “Striatal blood-brain barrier permeability in Parkinson’s disease,” Journal of Cerebral Blood Flow and Metabolism, vol. 35, no. 5, pp. 747–750, 2015. View at Publisher · View at Google Scholar
  37. A. Burgess, K. Shah, O. Hough, and K. Hynynen, “Focused ultrasound-mediated drug delivery through the blood–brain barrier,” Expert Review of Neurotherapeutics, vol. 15, no. 5, pp. 477–491, 2015. View at Publisher · View at Google Scholar
  38. C. P. Foley, D. G. Rubin, A. Santillan et al., “Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption,” Journal of Controlled Release, vol. 196, pp. 71–78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Yu, M. Ruan, X. Dong, Y. Yu, and H. Cheng, “The mechanism of the opening of the blood-brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study,” Journal of Ethnopharmacology, vol. 150, no. 3, pp. 1096–1108, 2013. View at Publisher · View at Google Scholar · View at Scopus